Takeshi Arashiro
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Disease burden and quality of life in caregivers of infants with RSV lower respiratory tract infections in Japan.
Journal: Japanese journal of infectious diseases
Published: July 01, 2026
Cost-effectiveness and public health impact of RSV immunization for all infants in Japan: a mixed strategy with nirsevimab and RSVpreF.
Journal: Expert review of vaccines
Published: June 23, 2026
Systematic Framework for Interpreting Laboratory-Confirmed Infectious Disease Surveillance Data: A Pragmatic Scenario-Based Approach.
Journal: Health security
Published: April 28, 2026
Experience conducting COVID-19 vaccine effectiveness studies in response to the COVID-19 pandemic in Japan and the Philippines: lessons for future epidemics and potential pandemics.
Journal: Western Pacific surveillance and response journal : WPSAR
Published: June 11, 2025
Spatial and temporal variability of respiratory syncytial virus disease seasonality in Japan, 2012-2024.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: May 16, 2025
Cost-effectiveness and public health impact of using high dose influenza vaccine in the Japanese older adults.
Journal: Journal of medical economics
Published: April 01, 2025
Sociobehavioural factors associated with SARS-CoV-2 infection and COVID-19 vaccine effectiveness against medically attended, symptomatic SARS-CoV-2 infection in the Philippines: a prospective case-control study (FASCINATE-P study).
Journal: Western Pacific surveillance and response journal : WPSAR
Published: March 04, 2025
Factors associated with COVID-19 in-hospital death and COVID-19 vaccine effectiveness against COVID-19 hospitalization in the Philippines during pre-omicron and omicron period: A case-control study (MOTIVATE-P study).
Journal: Epidemiology and infection
Published: December 20, 2024
A pluralistic approach to interpreting surveillance data: The likely decline in the occurrence of invasive pneumococcal disease in Japan during the COVID-19 pandemic.
Journal: Annals of epidemiology
Published: November 29, 2024
Cost-Effectiveness and Public Health Impact of Universal Prophylaxis with Nirsevimab Against Respiratory Syncytial Virus (RSV) Infections in all Infants in Japan.
Journal: Infectious diseases and therapy
Published: October 22, 2024
Respiratory Syncytial Virus Infection Notification Trends and Interpretation of the Reported Case Data, 2018-2021, Japan.
Journal: Japanese journal of infectious diseases
Published: September 29, 2024
Last Updated: 09/26/2026